Although evidence is accumulating that hydroxycarbamide decreases mortality among adults with sickle cell disease (SCD), there are no published data regarding the effect of hydroxycarbamide on mortality among children. The Paediatric Hydroxycarbamide Program was established to treat children with SC...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!